"Prima is delighted to have commenced patient enrollment for its pivotal trial of CVac™. With the first patient now enrolled in to the study, the Company expects to ramp-up enrolment through sites in Europe, Australasia and the US through 2012."
pr out!! first patient, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.8¢ | 31.0¢ | $464.7K | 1.479M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 938946 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 293429 | 34 |
View Market Depth
| Last trade - 14.40pm 08/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |